Last reviewed · How we verify
NCT06102668
Survival and PN Dependence in SBS Patients
trial in Short Bowel Syndrome in 173 participants. Completed in 1 January 2019.
1 January 2019
Quick facts
| Lead sponsor | The First Affiliated Hospital of University of Science and Technology of China |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 173 |
| Start date | 1 January 2012 |
| Primary completion | 1 January 2019 |
| Estimated completion | 1 January 2019 |
Conditions studied
- Short Bowel Syndrome — all drugs for Short Bowel Syndrome →
Sponsor
The First Affiliated Hospital of University of Science and Technology of China
Who can join
Adults 18 to 100, any sex, with Short Bowel Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Short bowel syndrome (SBS) is a rare condition resulting from the loss of portions of the small intestine, and can cause a spectrum of metabolic and physiologic disturbances.The objective of this study was to determine the longterm survival and parenteral nutrition dependence of adult patients with SBS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06102668
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Short Bowel Syndrome
Currently open trials in the same condition.
- NCT07197944 — Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS · Phase 3 · recruiting
- NCT05535361 — A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in A · NA · recruiting
- NCT06973304 — A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome · Phase 3 · recruiting
- NCT06326645 — Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome · EARLY_PHASE1 · recruiting
- NCT06771505 — SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Question · recruiting
Other The First Affiliated Hospital of University of Science and Technology of China trials
Trials by the same sponsor.
- NCT07449910 — Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A · Phase 2, PHASE3 · not yet recruiting
- NCT07168278 — Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT · Phase 3 · not yet recruiting
- NCT07214142 — Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer · Phase 2 · not yet recruiting
- NCT07094763 — Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-2 · NA · not yet recruiting
- NCT06559475 — A Multicenter, Randomized Controlled Clinical Investigation to Evaluate the Safety and Effectiveness of the Super-Bore 8 · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06102668 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of University of Science and Technology of China
- Last refreshed: 26 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06102668.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing